Global Montelukast Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Montelukast Drug

• 1.1 Definition of Montelukast Drug
• 1.2 Montelukast Drug Segment by Type
  • 1.2.1 Global Montelukast Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Tablet
  • 1.2.3 Chewable tablet
  • 1.2.4 Oral Granules
• 1.3 Montelukast Drug Segment by Applications
  • 1.3.1 Global Montelukast Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Drug store
  • 1.3.4 Others
• 1.4 Global Montelukast Drug Overall Market
  • 1.4.1 Global Montelukast Drug Revenue (2014-2025)
  • 1.4.2 Global Montelukast Drug Production (2014-2025)
  • 1.4.3 North America Montelukast Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Montelukast Drug Status and Prospect (2014-2025)
  • 1.4.5 China Montelukast Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Montelukast Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Montelukast Drug Status and Prospect (2014-2025)
  • 1.4.8 India Montelukast Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Montelukast Drug
• 2.3 Manufacturing Process Analysis of Montelukast Drug
• 2.4 Industry Chain Structure of Montelukast Drug

3 Development and Manufacturing Plants Analysis of Montelukast Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Montelukast Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Montelukast Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Montelukast Drug Production and Capacity Analysis
• 4.2 Montelukast Drug Revenue Analysis
• 4.3 Montelukast Drug Price Analysis
• 4.4 Market Concentration Degree

5 Montelukast Drug Regional Market Analysis

• 5.1 Montelukast Drug Production by Regions
  • 5.1.1 Global Montelukast Drug Production by Regions
  • 5.1.2 Global Montelukast Drug Revenue by Regions
• 5.2 Montelukast Drug Consumption by Regions
• 5.3 North America Montelukast Drug Market Analysis
  • 5.3.1 North America Montelukast Drug Production
  • 5.3.2 North America Montelukast Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Montelukast Drug Import and Export
• 5.4 Europe Montelukast Drug Market Analysis
  • 5.4.1 Europe Montelukast Drug Production
  • 5.4.2 Europe Montelukast Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Montelukast Drug Import and Export
• 5.5 China Montelukast Drug Market Analysis
  • 5.5.1 China Montelukast Drug Production
  • 5.5.2 China Montelukast Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Montelukast Drug Import and Export
• 5.6 Japan Montelukast Drug Market Analysis
  • 5.6.1 Japan Montelukast Drug Production
  • 5.6.2 Japan Montelukast Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Montelukast Drug Import and Export
• 5.7 Southeast Asia Montelukast Drug Market Analysis
  • 5.7.1 Southeast Asia Montelukast Drug Production
  • 5.7.2 Southeast Asia Montelukast Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Montelukast Drug Import and Export
• 5.8 India Montelukast Drug Market Analysis
  • 5.8.1 India Montelukast Drug Production
  • 5.8.2 India Montelukast Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Montelukast Drug Import and Export

6 Montelukast Drug Segment Market Analysis (by Type)

• 6.1 Global Montelukast Drug Production by Type
• 6.2 Global Montelukast Drug Revenue by Type
• 6.3 Montelukast Drug Price by Type

7 Montelukast Drug Segment Market Analysis (by Application)

• 7.1 Global Montelukast Drug Consumption by Application
• 7.2 Global Montelukast Drug Consumption Market Share by Application (2014-2019)

8 Montelukast Drug Major Manufacturers Analysis

• 8.1 Merck & Co.
  • 8.1.1 Merck & Co. Montelukast Drug Production Sites and Area Served
  • 8.1.2 Merck & Co. Product Introduction, Application and Specification
  • 8.1.3 Merck & Co. Montelukast Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Teva
  • 8.2.1 Teva Montelukast Drug Production Sites and Area Served
  • 8.2.2 Teva Product Introduction, Application and Specification
  • 8.2.3 Teva Montelukast Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Mylan
  • 8.3.1 Mylan Montelukast Drug Production Sites and Area Served
  • 8.3.2 Mylan Product Introduction, Application and Specification
  • 8.3.3 Mylan Montelukast Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Glenmark Pharmaceuticals
  • 8.4.1 Glenmark Pharmaceuticals Montelukast Drug Production Sites and Area Served
  • 8.4.2 Glenmark Pharmaceuticals Product Introduction, Application and Specification
  • 8.4.3 Glenmark Pharmaceuticals Montelukast Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Hikma Group
  • 8.5.1 Hikma Group Montelukast Drug Production Sites and Area Served
  • 8.5.2 Hikma Group Product Introduction, Application and Specification
  • 8.5.3 Hikma Group Montelukast Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Sandoz
  • 8.6.1 Sandoz Montelukast Drug Production Sites and Area Served
  • 8.6.2 Sandoz Product Introduction, Application and Specification
  • 8.6.3 Sandoz Montelukast Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Torrent Pharmaceuticals
  • 8.7.1 Torrent Pharmaceuticals Montelukast Drug Production Sites and Area Served
  • 8.7.2 Torrent Pharmaceuticals Product Introduction, Application and Specification
  • 8.7.3 Torrent Pharmaceuticals Montelukast Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Lannett Company
  • 8.8.1 Lannett Company Montelukast Drug Production Sites and Area Served
  • 8.8.2 Lannett Company Product Introduction, Application and Specification
  • 8.8.3 Lannett Company Montelukast Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Apotex
  • 8.9.1 Apotex Montelukast Drug Production Sites and Area Served
  • 8.9.2 Apotex Product Introduction, Application and Specification
  • 8.9.3 Apotex Montelukast Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Dr. Reddys Laboratories
  • 8.10.1 Dr. Reddys Laboratories Montelukast Drug Production Sites and Area Served
  • 8.10.2 Dr. Reddys Laboratories Product Introduction, Application and Specification
  • 8.10.3 Dr. Reddys Laboratories Montelukast Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Aurobindo Pharma
• 8.12 Accord Healthcare
• 8.13 Hetero
• 8.14 Unimark
• 8.15 Ajanta Pharma
• 8.16 MACLEODS
• 8.17 Jubilant Pharma
• 8.18 Unichem Laboratories
• 8.19 Amneal Pharmaceuticals
• 8.20 Shanghai Anbison Lab
• 8.21 Perrigo
• 8.22 Cipla
• 8.23 CSPC Ouyi Pharmaceutical

9 Development Trend of Analysis of Montelukast Drug Market

• 9.1 Global Montelukast Drug Market Trend Analysis
  • 9.1.1 Global Montelukast Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Montelukast Drug Regional Market Trend
  • 9.2.1 North America Montelukast Drug Forecast 2019-2025
  • 9.2.2 Europe Montelukast Drug Forecast 2019-2025
  • 9.2.3 China Montelukast Drug Forecast 2019-2025
  • 9.2.4 Japan Montelukast Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Montelukast Drug Forecast 2019-2025
  • 9.2.6 India Montelukast Drug Forecast 2019-2025
• 9.3 Montelukast Drug Market Trend (Product Type)
• 9.4 Montelukast Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Montelukast Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List